John P. Barratt serves as Executive at GENEREX BIOTECHNOLOGY CORP, where they oversee executive responsibilities. Since joining the company, John P. Barratt has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 27, 2015 involved exercising options for 5,874,162 shares valued at $0.
John P. Barratt currently holds 5,874,162 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John P. Barratt has been a net neutral trader of GNBT stock. They have purchased $0 and sold $0 worth of shares.
John P. Barratt's most recent insider trade was on Apr 27, 2015, when they sold 5,874,162 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 35,714 |
| $N/A |
| Discretionary |
| Feb 27, 2008 | GNBT | $70.0K | Option Exercise | 70,000 | $1.00 | Discretionary |
| May 30, 2006 | GNBT | $0 | Award | 150,000 | $N/A | Discretionary |